Glaxosmithkline Plc
Nov 08, 2011 at 06:12 | Source: Reuters
Jul 22, 2011 at 17:27 | Source: PTI
Nov 12, 2010 at 08:30 | Source: Reuters
Nov 10, 2010 at 09:35 | Source: Reuters
Oct 27, 2010 at 08:16 | Source: Reuters
Oct 12, 2010 at 10:00 | Source: Reuters
Photos »
/ 
News across the web »
May 25, 2012 at 16:22 | Source: Market Watch
May 24, 2012 at 06:00 | Source: Business Week
May 21, 2012 at 18:01 | Source: Wall Street Journal
May 18, 2012 at 04:00 | Source: Bloomberg
May 18, 2012 at 04:00 | Source: Business Week
Interact & exchange stock tips & market info »
Related News »
GlaxoSmithKline plc (the Company) announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2012 it purchased 1,785,000 of its Ordinary Shares of 25 pence each (Shares) on 28 May 2012.
May 27, 2012 at 23:54 | Source: 4-traders (press release)
GlaxoSmithKline PLC (GSK) - Director/PDMR Shareholding RNS Number : 3621E GlaxoSmithKline PLC 29 May 2012 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons ...
May 29, 2012 at 17:25 | Source: Bloomberg
GSK amends tender offer conditions to address Human Genome Sciences' adoption of poison pill GlaxoSmithKline plc (LSE: GSK) today announced that it has amended the conditions of its tender offer to acquire all of the outstanding shares of Human ...
May 23, 2012 at 13:00 | Source: FOXBusiness
GlaxoSmithKline PLC (>> GlaxoSmithKline plc), a global healthcare group, said Tuesday it purchased 1.8 million of its ordinary shares of 25 pence each, adding that it intends to hold these shares in treasury. -The highest price paid per Share was 1,440.5 ...
May 29, 2012 at 16:42 | Source: 4-traders (press release)
Tuesday, May 22, 2012... GlaxoSmithKline PLC (NYSE:GSK) closed Monday's bullish trading session at $44.48. In the past year, the stock has hit a 52-week low of $38.76 and..... Wednesday, May 16, 2012... GlaxoSmithKline PLC (NYSE:GSK) closed Tuesday's ...
May 29, 2012 at 11:55 | Source: Market Intelligence Center
GlaxoSmithKline plc (LSE: GSK) today commented on Human Genome Sciences (NASDAQ: HGSI) Board of Directors' decision to recommend against GSK's tender offer to acquire all of the outstanding shares of HGS for US$13.00 per share in cash.
May 17, 2012 at 17:32 | Source: FOXBusiness
(RTTNews) - GlaxoSmithKline plc (GSK: News ,GSK.L: News ) Wednesday amended the conditions of its unsolicited tender offer to acquire Human Genome Sciences (HGSI: News ) for $13.00 per share. The move, the British drug maker said, is in response to a ...
May 23, 2012 at 17:25 | Source: RTT News
Wednesday, May 16, 2012... GlaxoSmithKline PLC (NYSE:GSK) closed Tuesday's wandering trading session at $45.47. In the past year, the stock has hit a 52-week low of $38.76 and..... http://www.marketintelligencecenter.com/analyfav/1351640 Stocks Follow ...
May 22, 2012 at 12:11 | Source: Market Intelligence Center
NEW YORK (AP) -- British drug maker GlaxoSmithKline PLC has closed on a deal that boosts its interest in biotechnology company Theravance Inc. by 10 million shares. Theravance's shareholders approved the transaction on Tuesday. Last month ...
May 29, 2012 at 02:23 | Source: Yahoo Finance
GlaxoSmithKline PLC said Wednesday that Human Genome Sciences will need to drop a “poison pill” provision for the takeover of the biotech to move forward. Human Genome Sciences is GlaxoSmithKline’s partner in developing and marketing the ...
May 24, 2012 at 10:07 | Source: The Business Journal